| Literature DB >> 34926414 |
Matteo Pitton1,2, Andrea Fiorati1,2, Silvia Buscemi1, Lucio Melone1,2,3, Silvia Farè1,2, Nicola Contessi Negrini1,2.
Abstract
Pectin has found extensive interest in biomedical applications, including wound dressing, drug delivery, and cancer targeting. However, the low viscosity of pectin solutions hinders their applications in 3D bioprinting. Here, we developed multicomponent bioinks prepared by combining pectin with TEMPO-oxidized cellulose nanofibers (TOCNFs) to optimize the inks' printability while ensuring stability of the printed hydrogels and simultaneously print viable cell-laden inks. First, we screened several combinations of pectin (1%, 1.5%, 2%, and 2.5% w/v) and TOCNFs (0%, 0.5%, 1%, and 1.5% w/v) by testing their rheological properties and printability. Addition of TOCNFs allowed increasing the inks' viscosity while maintaining shear thinning rheological response, and it allowed us to identify the optimal pectin concentration (2.5% w/v). We then selected the optimal TOCNFs concentration (1% w/v) by evaluating the viability of cells embedded in the ink and eventually optimized the writing speed to be used to print accurate 3D grid structures. Bioinks were prepared by embedding L929 fibroblast cells in the ink printed by optimized printing parameters. The printed scaffolds were stable in a physiological-like environment and characterized by an elastic modulus of E = 1.8 ± 0.2 kPa. Cells loaded in the ink and printed were viable (cell viability >80%) and their metabolic activity increased in time during the in vitro culture, showing the potential use of the developed bioinks for biofabrication and tissue engineering applications.Entities:
Keywords: 3D printing; bioprinting; cellulose nanofiber; hydrogel; multicomponent bioink; pectin
Year: 2021 PMID: 34926414 PMCID: PMC8678092 DOI: 10.3389/fbioe.2021.732689
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Multicomponent pectin and TEMPO-Oxidized Cellulose Nanofibers (TOCNFs) hydrogels designed by varying the concentrations of the two components in the final inks. The first part of the name of the ink refers to the pectin concentration (Px), while the second part refers to the TOCNFs concentration (Cy).
| TOCNFs (% w/v) | |||||
|---|---|---|---|---|---|
|
| — | 0 | 0.5 | 1.0 | 1.5 |
| 1.0 | P1.0_C0 | P1_C0.5 | P1_C1 | P1_C1.5 | |
| 1.5 | P1.5_C0 | P1.5_C0.5 | P1.5_C1 | P1.5_C1.5 | |
| 2.0 | P2_C0 | P2_C0.5 | P2_C1 | P2_C1.5 | |
| 2.5 | P2.5_C0 | P2.5_C0.5 | P2.5_C1 | P2.5_C1.5 | |
FIGURE 1Evaluation of the printability of pectin-TOCNFs inks. (A) Shear rate ramp rheological tests on inks prepared by varying the concentration of pectin (P1, P1.5, P2, and P2.5) and TOCNFs (C0, C0.5, C1, and C1.5). (B) Macroscopic images of rings printed by varying the multicomponent inks composition (scale bar = 1 cm). (C) Comparison between the measured height of the printed rings and the theoretical height (dot line); *p < 0.05.
FIGURE 2Optimization of pectin-TOCNFs inks 3D printing. (A) Printing accuracy evaluated by varying the nozzle size (18, 20, and 22 G) and writing speed (12, 16, 20, and 24 mm/s); *p < 0.05; **p < 0.01; ***p < 0.001. (B) Optimization of the printing of 3D grid structures by varying the writing speed (12, 16, 20, and 24 mm/s, left) and microscopy images of the obtained 3D printed structures (scale bar = 2 mm, right); **p < 0.01; ***p < 0.001.
FIGURE 3Pectin-TOCNFs bioprinting. (A) Weight variation (left) and solid gel fraction (right) of the printed and bulk multicomponent hydrogels. (B) Compressive mechanical properties. Representative stress–strain curves (left) and elastic modulus E (right) of printed and bulk hydrogels. (C) In vitro cytocompatibility tests and bioprinting. Live/dead staining of cells embedded in bulk and printed hydrogels (left) and percentage cell viability (top right). Metabolic activity, tested by alamarBlue® assay, of cells cultured in bulk and printed hydrogels (bottom right); ***p < 0.001.